HUP9904131A3 - Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tomour necrosis factor (tnf) - Google Patents

Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tomour necrosis factor (tnf)

Info

Publication number
HUP9904131A3
HUP9904131A3 HU9904131A HUP9904131A HUP9904131A3 HU P9904131 A3 HUP9904131 A3 HU P9904131A3 HU 9904131 A HU9904131 A HU 9904131A HU P9904131 A HUP9904131 A HU P9904131A HU P9904131 A3 HUP9904131 A3 HU P9904131A3
Authority
HU
Hungary
Prior art keywords
tomour
mmp
tnf
inhibitors
necrosis factor
Prior art date
Application number
HU9904131A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Darwin Discovery Ltd Milton Ro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9523828.3A external-priority patent/GB9523828D0/en
Priority claimed from GBGB9607121.2A external-priority patent/GB9607121D0/en
Application filed by Darwin Discovery Ltd Milton Ro filed Critical Darwin Discovery Ltd Milton Ro
Publication of HUP9904131A2 publication Critical patent/HUP9904131A2/hu
Publication of HUP9904131A3 publication Critical patent/HUP9904131A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HU9904131A 1995-11-22 1996-11-22 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tomour necrosis factor (tnf) HUP9904131A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9523828.3A GB9523828D0 (en) 1995-11-22 1995-11-22 Compounds
GBGB9607121.2A GB9607121D0 (en) 1996-04-04 1996-04-04 Compounds
PCT/GB1996/002892 WO1997019075A1 (en) 1995-11-22 1996-11-22 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf)

Publications (2)

Publication Number Publication Date
HUP9904131A2 HUP9904131A2 (hu) 2000-06-28
HUP9904131A3 true HUP9904131A3 (en) 2002-04-29

Family

ID=26308152

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904131A HUP9904131A3 (en) 1995-11-22 1996-11-22 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tomour necrosis factor (tnf)

Country Status (19)

Country Link
US (1) US6048841A (enExample)
EP (1) EP0874842B1 (enExample)
JP (1) JP2000500482A (enExample)
KR (1) KR19990067687A (enExample)
CN (1) CN1072667C (enExample)
AT (1) ATE215946T1 (enExample)
AU (1) AU711907B2 (enExample)
BR (1) BR9611636A (enExample)
CA (1) CA2229438C (enExample)
CZ (1) CZ291337B6 (enExample)
DE (1) DE69620639T2 (enExample)
ES (1) ES2172690T3 (enExample)
HU (1) HUP9904131A3 (enExample)
IL (1) IL123431A (enExample)
MX (1) MX9804052A (enExample)
NO (1) NO982290L (enExample)
NZ (1) NZ322565A (enExample)
PL (1) PL326710A1 (enExample)
WO (1) WO1997019075A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
RU2201931C2 (ru) 1996-11-20 2003-04-10 Биомежер Инкорпорэйтед Ингибиторы фарнезилтрансферазы и способы ингибирования фарнезилтрансферазы
CA2408408C (en) 2000-05-12 2013-07-09 Genzyme Corporation Modulators of tnf- alpha signaling
EP1282614B1 (en) 2000-05-15 2003-11-12 Darwin Discovery Limited Hydroxamic acid derivatives
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
DE60305446T4 (de) * 2002-01-07 2009-07-09 Eisai R&D Management Co., Ltd. Desazapurine und deren verwendung
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
DE60335652D1 (de) * 2002-11-21 2011-02-17 Genzyme Corp Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung
AU2003291143A1 (en) * 2002-11-21 2004-06-18 Genzyme Corporation Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance
US20040259744A1 (en) * 2003-12-19 2004-12-23 Meidong Yang Skin and hair cleansers containing sulfur
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
PL227790B1 (pl) 2015-08-13 2018-01-31 Slaski Univ Medyczny W Katowicach Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie.
CN120617250A (zh) * 2025-07-04 2025-09-12 南京农业大学 小分子化合物Nec-1s在制备治疗脑膜炎药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525629A (en) * 1992-04-07 1996-06-11 British Bio-Technology Limited Inhibition of cytokine production
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds
GB9404046D0 (en) * 1994-03-03 1994-04-20 Smithkline Beecham Corp Novel compounds
JP3787605B2 (ja) * 1994-10-05 2006-06-21 ダーウィン・ディスカバリー・リミテッド ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用

Also Published As

Publication number Publication date
CA2229438A1 (en) 1997-05-29
AU711907B2 (en) 1999-10-21
BR9611636A (pt) 1999-12-28
IL123431A0 (en) 1998-09-24
ES2172690T3 (es) 2002-10-01
CN1072667C (zh) 2001-10-10
JP2000500482A (ja) 2000-01-18
IL123431A (en) 2001-05-20
DE69620639T2 (de) 2002-10-17
EP0874842A1 (en) 1998-11-04
CN1202895A (zh) 1998-12-23
ATE215946T1 (de) 2002-04-15
HUP9904131A2 (hu) 2000-06-28
AU7634396A (en) 1997-06-11
MX9804052A (es) 1998-09-30
NO982290D0 (no) 1998-05-20
WO1997019075A1 (en) 1997-05-29
CZ145598A3 (cs) 1998-08-12
KR19990067687A (ko) 1999-08-25
PL326710A1 (en) 1998-10-26
NO982290L (no) 1998-05-20
US6048841A (en) 2000-04-11
CZ291337B6 (cs) 2003-02-12
DE69620639D1 (de) 2002-05-16
EP0874842B1 (en) 2002-04-10
CA2229438C (en) 2006-01-17
NZ322565A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
AU4267293A (en) Use of MMP inhibitors
IL123431A0 (en) Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (MMP) and/or tumour necrosis factor (TNF)
PL330974A1 (en) Substituted derivatives of indazole and their application as inhibitors of phosphodiesterase (pde) of iv type and of tumor necrosis factor (tnf)
FI973974A7 (fi) Aryylisulfonyylihydroksaamihappojohdannaisia MMP- ja TNF-inhibiittorei na
AU1116497A (en) Inhibitors of cyclin-dependent kinases
PL319503A1 (en) Peptide compounds and their therapeutic application as inhibitors
AU4915796A (en) Inhibitors of prenyl transferases
PL332187A1 (en) Substitution derivatives of indazole and their application as inhibitors of phosphodiesterase (pde) of iv type and tumor necrosis factor (tnf)
PL329836A1 (en) Substituted indazole derivatives and their application as inhibitors of phosphosiesterase (pde) type iv and of tumor necrosis factor (tnf) formation
PL327185A1 (en) Thyrosine derivatives as inhibitors of integrin-alpha v
AU5918494A (en) Heterocyclic inhibitors of farnesyl protein transferase
AU8760798A (en) Irreversible inhibitors of tyrosine kinases
AU5453994A (en) Inhibitors of farnesyl-protein transferase
AU5665396A (en) Novel hydroxamic acid and amino-carboxylate compounds as met alloprotease and tnf inhibitors
AU1988495A (en) Inhibitors of farnesyl-protein transferase
PL331254A1 (en) Phosphonianic inhibitors of matrix metaloproteases
PL327569A1 (en) Promedications of thrombosin inhibitors
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU3373195A (en) Inhibitors of farnesyl-protein transferase
PL331047A1 (en) Novel amidinic derivatives and their application as inhibitors of thrombosin
AU9663798A (en) Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
AU1417092A (en) 1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity
PL333112A1 (en) Substitute derivatives of 4-biphenyl-4-hydroxybutyric acid as inhibitors of matrix metaloproteases
AU2159495A (en) Methods and compositions for inhibition of hepatic clearance of tissue factor pathway inhibitor
AU1783092A (en) Inhibitors of protein kinase c function